Desórdenes neurológicos

Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor [EN] - Sep 17, 2014

Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise™ Deep Brain Stimulation (DBS) System for the treatment of tremor, including ...

Leer más

Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System [EN] - Jun 11, 2014

Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System demonstrated a highly significant  ...

Leer más

VER TODAS LAS NOTAS DE PRENSA

2014

Contactos para los medios

Dina Hurtado García
Health Economics &
Public Affairs España
+34 6291 294 31
HurtadoD@bsci.com

Perfil de la Compañía
Top